TrialClinical and translational science2025

Phase 1 Study Evaluating the Pharmacokinetics, Dose Proportionality, Bioavailability, and Tolerability of Subcutaneous Levothyroxine Sodium (XP-8121).

Richard Fitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.